Ethos And Stereotypes

In the field of molecular biology, one topic that provokes controversy centers on the role of tumor size in cancer. Consequently, Kasangian published an article titled “The prognostic role of tumor size in early breast cancer in the era of molecular biology.” Being a recent article, it presents data from extensive research of tumors and its different types. The author primarily backs up her research by starting from the basics of what a tumor is and expanding on the details, mentioning different dimensions and molecular subtypes. In this 2017 PLOS ONE issue, she effectively uses clear logic and evidence in her claim that the strongest determinant of breast cancer survival is the molecular subtype. In this article, the author’s audience is

This is because she is trying to be a credible source and be straightforward about cancer. Although, it is still there if the person reading it has breast cancer or knows someone with it, because they may feel emotional at the statistics. Sometimes cancer can have a low survival rate and in the article she looks more at finding a solution with the proper data rather than leaving it uncured. Because of the seriousness of her topic, she doesn’t switch up her emotion throughout the article. Her tone is factual and honest. Ethos is established by the writer and her history in working in a breast cancer unit. She is constantly doing research for cures and subtypes, so she is a good, trustworthy

These charts show things such as tumor characteristics and the type of surgery needed according to molecular subtype. Therefore, the writer’s style is very academic and formal. She sounds very educated in her field and knows what she is talking about. She definitely took her time conducting this article and collected all of the evidence she could in advance. She is an eye opener in the field of cancer. She proves that these characteristics: age,tumor size, TV, histological grade and molecular subtype are effective in terms of curing cancer. This is based upon her research and experience with diagnosing patients with breast cancer. In other words, she does an effective job in presenting her data and educating the reader on tumors, even if they may not be well informed in the first